Thus, we next tested whether TAGLN2 enables the use of these fatty acids to sustain mitochondrial activity in activated CD8+ T cells experiencing glucose restriction (Fig. 5i), which is a prevalent condition in the tumor milieu. The gene discussed is TAGLN2; the disease is neoplasm.